Wechsler‐Reya, Robert J.
https://orcid.org/0000-0002-7463-8352
Mayo Clinic
Sanford Burnham Prebys Medical Discovery Institute
Citations 2
Sleeping Beauty Insertional Mutagenesis Reveals Important Genetic Drivers of Central Nervous System Embryonal Tumors
Beckmann, Pauline J. , Larsson, Alex T. , Ostergaard, Jason, Wagner, Sandra, Rahrmann, Eric P. , Shamsan, Ghaidan A. , Otto, George M. , Williams, Rory L. , Wang, Jun , Lee, Catherine , Tschida, Barbara R. , Das, Paramita , Dubuc, Adrian M. , Moriarity, Branden S. , Picard, Daniel , Wu, Xiaochong , Rosemarie, Quincy , Krebs, Ryan D., Molan, Amy M. , Demer, Addison M. , Frees, Michelle M. , Rizzardi, Anthony E., Schmechel, Stephen C. , Jenkins, Robert B. , Wechsler‐Reya, Robert J. , Odde, David J. , Taylor, Michael D. , Sarver, Aaron L. , Largaespada, David A. , Rahrmann, Eric P , Shamsan, Ghaidan A , Williams, Rory L , Picard, Daniel , Rosemarie, Quincy , Odde, David J , Larson, Jon D. , Wagner, Sandra, Tschida, Barbara R , Rodríguez, Fausto J. , Krebs, Ryan D., Eberhart, Charles G. , Huang, Annie , Largaespada, David A.
Cancer Research | January 23, 2019 | Volume: 79 | Issue: 5 | Pages: 905-917
Abstract Medulloblastoma and central nervous system primitive neuroectodermal tumors (CNS-PNET) are aggressive, poorly differentiated brain tumors with limited effective therapies. Using Sleeping Beauty (SB) transposon mutagenesis, we identified novel genetic drivers of medulloblastoma and CNS-PNET. Cross-species gene expression analyses classified SB-driven tumors into distinct medulloblastoma and CNS-PNET subgroups, indicating they resemble human Sonic hedgehog and group 3 and 4 medulloblastoma and CNS neuroblastoma with FOXR2 activation. This represents the first genetically induced mouse model of CNS-PNET and a rare model of group 3 and 4 medulloblastoma. We identified several putative proto-oncogenes including Arhgap36, Megf10, and Foxr2. Genetic manipulation of these genes demonstrated a robust impact on tumorigenesis in vitro and in vivo. We also determined that FOXR2 interacts with N-MYC, increases C-MYC protein stability, and activates FAK/SRC signaling. Altogether, our study identified several promising therapeutic targets in medulloblastoma and CNS-PNET. Significance: A transposon-induced mouse model identifies several novel genetic drivers and potential therapeutic targets in medulloblastoma and CNS-PNET.
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Meehan, Terrence F. , Goldstein, Theodore C. , Murakami, Mark A. , Brabetz, Sebastian , Gu, Zhiping , Wiser, Jeffrey A., Dunn, Patrick , Begley, Dale A. , Krupke, Debra M. , Bertotti, Andrea , Bruna, Alejandra , Brush, Matthew , Byrne, Annette T. , Caldas, Carlos , Christie, Amanda L., Clark, Dominic A. , Dowst, Heidi , Dry, Jonathan R. , Doroshow, James H. , Duchamp, Olivier, Ferretti, Stéphane , Frese, Kristopher K. , Goodwin, Neal , Greenawalt, Danielle M., Haendel, Melissa , Hermans, Els , Houghton, Peter J. , Jonkers, Jos , Kemper, Kristel , Khor, Tin Oo, Lloyd, K. C. Kent , Mason, Jeremy , Médico, Enzo , Olson, James M. , Peeper, Daniel S. , Seong, Je Kyung , Trusolino, Livio , Vinolo, Emilie, Wechsler‐Reya, Robert J. , Weinstock, David M. , Welm, Alana L. , Weroha, S. John , Pfister, Stefan M. , Kool, Marcel , Parkinson, Helen , Butte, Atul J. , Bult, Carol J. , Haendel, Melissa , Caldas, Carlos , Pfister, Stefan M , Conte, Nathalie , Inghirami, Giorgio , Evrard, Yvonne A. , Lewis, Michael T. , Neuhauser, Steven B. , Rueda, Oscar M. , Amant, Frédéric
Cancer Research | November 1, 2017 | Volume: 77 | Issue: 21 | Pages: e62-e66
Abstract Patient-derived tumor xenograft (PDX) mouse models have emerged as an important oncology research platform to study tumor evolution, mechanisms of drug response and resistance, and tailoring chemotherapeutic approaches for individual patients. The lack of robust standards for reporting on PDX models has hampered the ability of researchers to find relevant PDX models and associated data. Here we present the PDX models minimal information standard (PDX-MI) for reporting on the generation, quality assurance, and use of PDX models. PDX-MI defines the minimal information for describing the clinical attributes of a patient's tumor, the processes of implantation and passaging of tumors in a host mouse strain, quality assurance methods, and the use of PDX models in cancer research. Adherence to PDX-MI standards will facilitate accurate search results for oncology models and their associated data across distributed repository databases and promote reproducibility in research studies using these models. Cancer Res; 77(21); e62–66. ©2017 AACR.